Stockreport

Candel Therapeutics: 'Cancer Vaccine' Buy Thesis Appears Compelling [Seeking Alpha]

Candel Therapeutics, Inc.  (CADL) 
PDF CADL's aglatimagene has demonstrated statistically significant improvements in disease-free survival and safety, supporting a strong case for FDA approval and commercia [Read more]